93 148 Pill - orange oval, 14mm
Pill with imprint 93 148 is Orange, Oval and has been identified as Naproxen 375 mg. It is supplied by Teva Pharmaceuticals USA.
Naproxen is used in the treatment of Back Pain; Ankylosing Spondylitis; Bursitis; Muscle Pain; Chronic Myofascial Pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Naproxen 375 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 148
Naproxen
- Imprint
- 93 148
- Strength
- 375 mg
- Color
- Orange
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Rx and/or OTC
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
magnesium stearate,
povidone k90,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-0148 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 54569-3759 | A-S Medication Solutions, LLC (repackager) |
| 49999-0049 | Lake Erie Medical and Surgical Supply (repackager) |
More about naproxen
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (681)
- Drug images
- Latest FDA alerts (8)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
Patient resources
Other brands
Aleve, Naprosyn, Anaprox, Flanax Pain Reliever, ... +6 more
Professional resources
- Naproxen monograph
- Naproxen (FDA)
- Naproxen CR Tablets (FDA)
- Naproxen Capsules (FDA)
- Naproxen Delayed Release (FDA)
- Naproxen Tablets (FDA)
Other brands
Aleve, Naprosyn, Naprelan, All Day Pain Relief, All Day Relief
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.